RT Journal Article
SR Electronic
T1 Radiographic Assessment of Lung Edema (RALE) Scores are Highly Reproducible and Prognostic of Clinical Outcomes for Inpatients with COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.06.10.22276249
DO 10.1101/2022.06.10.22276249
A1 Al-Yousif, Nameer
A1 Komanduri, Saketram
A1 Qurashi, Hafiz
A1 Korzhuk, Anatoliy
A1 Lawal, Halimat O.
A1 Abourizk, Nicholas
A1 Schaefer, Caitlin
A1 Mitchell, Kevin J.
A1 Dietz, Catherine M.
A1 Hughes, Ellen K.
A1 Brandt, Clara S.
A1 Fitzgerald, Georgia M.
A1 Joyce, Robin
A1 Chaudhry, Asmaa S.
A1 Kotok, Daniel
A1 Rivera, Jose D.
A1 Kim, Andrew I.
A1 Shettigar, Shruti
A1 Lavina, Allen
A1 Girard, Christine E.
A1 Gillenwater, Samantha R.
A1 Hadeh, Anas
A1 Bain, William
A1 Shah, Faraaz A.
A1 Bittner, Matthew
A1 Lu, Michael
A1 Prendergast, Niall
A1 Evankovich, John
A1 Golubykh, Konstantin
A1 Ramesh, Navitha
A1 Jacobs, Jana J.
A1 Kessinger, Cathy
A1 Methé, Barbara
A1 Lee, Janet S.
A1 Morris, Alison
A1 McVerry, Bryan J.
A1 Kitsios, Georgios D.
YR 2022
UL http://medrxiv.org/content/early/2022/06/14/2022.06.10.22276249.abstract
AB INTRODUCTION Chest imaging is necessary for diagnosis of COVID-19 pneumonia, but current risk stratification tools do not consider radiographic severity. We quantified radiographic heterogeneity among inpatients with COVID-19 with the Radiographic Assessment of Lung Edema (RALE) score on Chest X-rays (CXRs).METHODS We performed independent RALE scoring by ≥2 reviewers on baseline CXRs from 425 inpatients with COVID-19 (discovery dataset), we recorded clinical variables and outcomes, and measured plasma host-response biomarkers and SARS-CoV-2 RNA load from subjects with available biospecimens.RESULTS We found excellent inter-rater agreement for RALE scores (intraclass correlation co-efficient=0.93). The required level of respiratory support at the time of baseline CXRs (supplemental oxygen or non-invasive ventilation [n=178]; invasive-mechanical ventilation [n=234], extracorporeal membrane oxygenation [n=13]) was significantly associated with RALE scores (median [interquartile range]: 20.0[14.1-26.7], 26.0[20.5-34.0] and 44.5[34.5-48.0], respectively, p<0.0001). Among invasively-ventilated patients, RALE scores were significantly associated with worse respiratory mechanics (plateau and driving pressure) and gas exchange metrics (PaO2/FiO2 and ventilatory ratio), as well as higher plasma levels of IL-6, sRAGE and TNFR1 levels (p<0.05). RALE scores were independently associated with 90-day survival in a multivariate Cox proportional hazards model (adjusted hazard ratio 1.04[1.02-1.07], p=0.002). We validated significant associations of RALE scores with baseline severity and mortality in an independent dataset of 415 COVID-19 inpatients.CONCLUSION Reproducible assessment of radiographic severity revealed significant associations with clinical and physiologic severity, host-response biomarkers and clinical outcome in COVID-19 pneumonia. Incorporation of radiographic severity assessments may provide prognostic and treatment allocation guidance in patients hospitalized with COVID-19.Competing Interest StatementDr. Kitsios has received research funding from Karius, Inc in 2018-2019. Dr. McVerry receives research funding from Bayer Pharmaceuticals, Inc. All other authors disclosed no conflict of interest.Funding StatementDr. Kitsios: University of Pittsburgh Clinical and Translational Science Institute, COVID-19 Pilot Award; NIH (K23 HL139987)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of University of Pittsburgh Medical Center (UPMC) gave ethical approval for this work for our cohorts from UPMC. IRB protocol STUDY19050099, IRB protocol STUDY20040036 & IRB protocol 20E059. IRB of the Cleveland Clinic systems gave ethical approval for this work for the cohort from Cleveland Clinic systems. (FLA 20-038)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript